NAD+

Overview

It's completely reasonable — and intelligent — to be curious about NAD+.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell. Strictly speaking it is a dinucleotide rather than a peptide — this library includes it because infusible NAD+ and its oral precursors (NMN, nicotinamide riboside) are widely studied and marketed in the same channels as peptide therapeutics.

People researching NAD+ are typically asking a genuinely big question: can restoring one of the cell's most fundamental coenzymes influence how we age?

The Science: A Coenzyme at the Center of Everything

Think of NAD+ as cellular currency that several major systems all spend:

• Energy metabolism: Redox reactions in glycolysis, the TCA cycle, and oxidative phosphorylation depend on NAD+/NADH cycling.
• Sirtuin activation: NAD+ is a required substrate for the sirtuin family of deacetylases, enzymes linked to longevity pathways in multiple model organisms.
• PARP and DNA repair: PARPs consume NAD+ during DNA damage response — linking genome maintenance directly to NAD+ availability.
• CD38 and cellular signaling: CD38 consumes NAD+, and its activity increases with age — one of the proposed reasons NAD+ pools decline over time.

Because cellular NAD+ levels decline in multiple tissues with aging, much of the research asks whether restoring NAD+ pools produces functional benefit or simply raises a biomarker.

What Researchers Have Observed

The evidence spans preclinical work and a growing clinical base:

• Mitochondrial health: Rodent studies report improved mitochondrial function, enhanced endurance, and age-related metabolic improvements with NAD+ precursor supplementation.
• Cardiometabolic health: Human NR trials (Martens 2018 and follow-ups) have shown elevated whole-blood NAD+ metabolites, improved blood pressure in certain populations, and favorable lipid signals.
• Muscle and physical function: Research in older adults has examined effects on muscle strength and mitochondrial capacity, with small effect sizes emerging in some trials.
• Neurodegenerative disease: Early-stage research explores NAD+ restoration in Parkinson's disease, Alzheimer's disease, and peripheral neuropathy.
• Skin and aging biomarkers: Topical NAD+ precursors are an active cosmetic research area, and systemic precursors are studied against epigenetic clocks.

The Empowerment Angle: Quality of Life Research

Many people researching NAD+ aren't expecting a fountain of youth. They're exploring:

• How aging actually works at the cellular level — the kind of literacy that changes how people approach their own health
• What sirtuin biology means and why it's been such a durable theme in longevity research
• The relationship between energy, recovery, and cellular repair across their own life
• Biomarker tracking — whole-blood NAD+, metabolites, and functional measures — as a form of informed self-study
• Contributing to citizen science through thoughtful documentation during an ongoing research story

Learning about redox biology, the NAD+ salvage pathway, CD38, and sirtuins gives anyone researching NAD+ a much richer view of aging biology as a whole.

State of the Evidence

NAD+ precursors have one of the more robust human evidence bases among longevity-adjacent compounds:

• Oral precursors (NR, NMN) have substantial published human safety and pharmacokinetic data
• Multiple placebo-controlled trials establish that blood NAD+ metabolites rise reliably with supplementation
• Consistent effects on hard clinical endpoints (functional aging, disease progression) remain early-stage
• Parenteral NAD+ as administered in wellness clinics has a much thinner peer-reviewed evidence base than the oral-precursor literature
• Long-term outcome data is still accumulating

This is the classic "biomarker moves reliably, endpoint still being established" situation — interesting to research, worth understanding carefully.

Approaching Research Responsibly

If you're researching NAD+ or its precursors, the most grounded approach combines curiosity with care:

The most mature approach isn't blind optimism or reflexive skepticism, but curious, methodical, well-informed self-experimentation.

This entry is designed to help you understand both the science and the human motivation behind researching NAD+. The goal is informed curiosity and empowerment, not medical advice.

References

1. [1]Rajman L et al. Therapeutic potential of NAD-boosting molecules: the in vivo evidence(2018) · doi:10.1016/j.cmet.2018.02.011
2. [2]Martens CR et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults(2018) · doi:10.1038/s41467-018-03421-7
3. [3]Conlon N, Ford D. A systems-approach to NAD+ restoration(2022) · doi:10.1016/j.bcp.2022.114946